Olympic champion Peres Jepchirchir provisionally suspended over EPO positive, Sydney title in doubt

Olympic gold medallist and world champion Kenyan marathon runner Peres Jepchirchir has been provisionally suspended by the Athletics Integrity Unit (AIU) after an out-of-competition sample she provided tested positive for erythropoietin (EPO). According to the available information, the 33-year-old provided the sample in Kenya before winning the Sydney Marathon on 30 August 2026. She clocked two hours, 18 minutes and 31 seconds to take the title in Sydney. The Sydney Marathon became the seventh Abbott World Marathon Major in 2026, and Jepchirchir won it on her first appearance at the newest major on the circuit. She finished more than three minutes clear of her compatriot Irene Chepet Cheptai — a wide margin over the marathon distance. The victory had further cemented her place among the most decorated women's marathon runners in the world, but that achievement is now shrouded in controversy. EPO, or erythropoietin, is a natural substance produced within the kidneys that stimulates the creation of new red blood cells. If injected, it is detectable in urine or blood only for a short window of time, and it increases the number of red blood cells, which carry oxygen to the muscles, in the bloodstream. Because of that effect, EPO has long been regarded as the most notorious tool of blood doping in endurance sport, and it sits on the World Anti-Doping Agency's (WADA) prohibited list under the peptide hormones and growth factors category. A provisional suspension does not mean guilt has been established. The AIU — the independent anti-doping body of World Athletics — first completes its investigation before the disciplinary process moves forward. Under the standard process, the athlete has the right to respond, to request analysis of the B sample and to defend herself at a hearing. Until a final decision is reached, she cannot compete. No official reaction from the athlete has so far been made public, and it is not yet clear on what grounds her defence will rest. If the positive finding is ultimately upheld, the consequences could be severe. Under the World Anti-Doping Code, cases involving substances such as EPO typically carry a period of ineligibility of up to four years, unless the athlete can establish that the use was not intentional and a basis for reducing the sanction exists. In addition, results, prize money and ranking points from the date of the sample onwards can be annulled. Because the sample was collected before the Sydney Marathon, the title, prize money and records from that race could in theory also be called into question — although in such cases the outcome is announced only after the procedures of the relevant federation and race organisers are completed. Jepchirchir's career is counted among the most consistent successes in women's marathon running over the past decade. She became the Olympic women's marathon champion at the 2026 Tokyo Olympics and returned to the same city in September 2026 to win the World Championships title. She broke the women's half-marathon world record in 2026 and set it on three further occasions in 2026. In addition to Sydney, her major wins came at the New York Marathon in 2026, the Boston Marathon in 2026 and the London Marathon in 2026. Kenya has long been the centre of the world's strongest distance-running tradition, but doping cases involving its athletes have also repeatedly made headlines. In recent years the AIU and the national anti-doping agency have stepped up testing and investigations in Kenya, and several leading runners have faced sanctions. That backdrop raises the significance of this case, because out-of-competition testing is precisely what demonstrates that the rules do not stop at race day. The fallout could be felt on several levels. First, on the majors' standings and the season's points, since the points and prize money earned in Sydney could become part of the dispute. Second, on her sponsors and management team, who in such cases usually stay silent and wait for the legal process. Third, on the competitive shape of women's marathon running — if she is sidelined for a long period, a major place will open up in the build-up to the 2028 Los Angeles Olympic cycle. It is important to understand that doping cases often run for months. Confirmation of the sample, the exchange of documents, a hearing and a possible appeal — each stage takes time. Jumping to conclusions would therefore be premature. At the same time, for the credibility of the sport it matters that the process remains transparent and that the athlete is given a full opportunity to present her case. In the meantime, the marathon world is watching the AIU's next move. The question is whether this will remain an individual dispute, or whether it will give fresh momentum to the wider debate over whether testing for substances such as EPO in endurance sport should be made even more intensive. Either way, one thing is clear — the hardest stretch of the career of a woman who has won gold at both the Olympics and the World Championships has only just begun, and its end will be decided at the rulebook and the hearing table, not on the track.